ITI Pharma and Healthcare Fund Regular vs SBI Healthcare Opportunities Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹236 Cr | ₹4027 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 31 Dec 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 32% |
Expense Ratio | 2.35 | 1.94 |
Manager | Rohan Korde | Pradeep Kesavan |
ISIN Code | INF00XX01BL5 | INF200K01446 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Month | -1.92% | -1.03% |
6 Month | 8.07% | 10.12% |
1 Year | 3.3% | 10.79% |
3 Year | 21.21% | 27.13% |
5 Year | - | 20.46% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
6 Month | 2.6% | 3.36% |
1 Year | 1.34% | 7.57% |
3 Year | 20.4% | 25.09% |
5 Year | - | 21.31% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Year | 19.5% | 16.04% |
3 Year | 19.53% | 17.71% |
5 Year | - | 12.85% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Standard Deviation | 15.16% | 13.57% |
Sharp | 0.98% | 1.42% |
Beta | 0.94% | 0.84% |
Alpha | -1.87% | 4.50% |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Name | Rohan Korde | Pradeep Kesavan |
Total AUM | ₹4626 Cr | ₹434274 Cr |
Funds Managed | 10 | 43 |
ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 3.17 | 12.03 |
Mid Cap | 37.04 | 27.95 |
Small Cap | 32.68 | 33.75 |
Large Cap | 27.1 | 26.26 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 1.29 | 2.38 |
Healthcare | 91.09 | 91.66 |
Basic Materials | 5.09 | 5.96 |
Industrials | 1.81 | - |
Financial Services | 0.73 | - |
Top Comparisons
Nippon India Index Fund - Nifty 50 Plan - Growth Plan - Growth Option
3Y Returns12.63%
UTI Nifty Next 50 Index Fund - Regular Plan - Growth Option
3Y Returns16.2%
SBI Credit Risk Fund - Regular Plan - Growth
3Y Returns7.97%
HSBC Credit Risk Fund - Regular Growth
3Y Returns11.04%
Tata Nifty MidSmall Healthcare Index Fund-Reg (G)
3Y Returns0%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Regular Plan - Growth
3Y Returns20.17%
Franklin India Aggressive Hybrid Fund - Growth Plan
3Y Returns15.1%
INVESCO INDIA AGGRESSIVE HYBRID FUND - Regular Plan - Growth
3Y Returns16.37%